# Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer

> **NCT07659639** · NA · RECRUITING · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 400 (estimated)

## Conditions studied

- Diabetes
- IPMN, Pancreatic
- PDAC - Pancreatic Ductal Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic procedures

## Key facts

- **NCT ID:** NCT07659639
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07659639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07659639, "Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07659639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*